SCHEMBL14236085

SCHEMBL14236085

FC(F)(F)c1ccc(CNc2ccc(CC3CNc4ncc(OCCN5CCOCC5)cc43)cn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KB1 P23443 3/20 0.45
▸ AURKA O14965 2/20 0.45
▸ PDPK1 O15530 1/20 0.45
▸ AURKB Q96GD4 1/20 0.41
▸ CSF1R P07333 2/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ BCR P11274 1/20 0.39
▸ EPHX2 P34913 5/20 0.38
▸ CACNA1B Q00975 2/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ PPARG P37231 1/20 0.37
▸ PPARD Q03181 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ TIPARP Q7Z3E1 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ EPAS1 Q99814 1/20 0.37
▸ CACNA1H O95180 1/20 0.37
▸ KDR P35968 2/20 0.36
▸ FLT3 P36888 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12925721 0.93 CACNA1B (0.44) RPS6KB1AURKAPDPK1CSF1RCACNA1B
SCHEMBL12341435 0.84 RPS6KB1 (0.42) RPS6KB1AURKAPDPK1AURKBCSF1R
SCHEMBL12342109 0.82 CSF1R (0.42) RPS6KB1AURKACSF1RCACNA1BKIT
SCHEMBL12304343 0.79 CSF1R (0.43) AURKBCSF1REPHX2KDRFLT3
SCHEMBL1267328 0.77 CSF1R (0.68) RPS6KB1AURKAPDPK1AURKBCSF1R
SCHEMBL13056388 0.76 CSF1R (0.52) CSF1REPHX2KIT
SCHEMBL12342164 0.73 CSF1R (0.52) RPS6KB1AURKAPDPK1AURKBCSF1R
SCHEMBL12341431 0.73 CSF1R (0.49) RPS6KB1AURKAPDPK1AURKBCSF1R
SCHEMBL1267604 0.69 CSF1R (0.71) RPS6KB1AURKAPDPK1AURKBCSF1R
SCHEMBL24594059 0.69 CSF1R (0.54) AURKBCSF1RKDRFLT3KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120309756-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR PLEXXIKON INC 2012-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309756-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR KIT, FLT3, FLT1 RPS6KB1 619/4885AURKA 666/4885PDPK1 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback